Daria Gerasimova Data-verified
Affiliation confirmed via AI analysis of OpenAlex, ORCID, and web sources.
Researcher
faculty
Research Areas
Links
Biography and Research Information
OverviewAI-generated summary
Daria Gerasimova's research focuses on understanding and improving educational outcomes for students with disabilities. She investigates the quality of Individualized Education Programs (IEPs) in relation to special education placement and explores the ecobehavioral analysis of students with complex support needs across different classroom settings. Gerasimova also examines the self-determination outcomes for racially and ethnically marginalized students with disabilities in inclusive general education classrooms. Her work includes the development and assessment of tools like the Goal Setting Challenge App to impact transition goal attainment for students with disabilities. She has published extensively on best practices for addressing missing data through multiple imputation, with a h-index of 8 and 374 total citations across 43 publications. Key collaborators include Tyler A. Hicks, Sheida K. Raley, Darcy Fredrick, and Stephen M. Kwiatek, all from the University of Arkansas at Fayetteville.
Metrics
- h-index: 8
- Publications: 43
- Citations: 381
Selected Publications
-
Conceptualizing Fidelity of Implementation of a Technology-Delivered Self-Determination Intervention (2025)
Collaboration Network
Top Collaborators
- Exploring Self-Determination Outcomes of Racially and Ethnically Marginalized Students With Disabilities in Inclusive, General Education Classrooms
- Ecobehavioral Analysis of the Experiences of Students With Complex Support Needs in Different Classroom Types
- An Investigation of IEP Quality Associated With Special Education Placement for Students With Complex Support Needs
- The Goal Setting Challenge App: Impact on Transition Goal Attainment Outcomes of Students With Disabilities
- Preliminary Reliability and Validity of the Self-Determination Inventory: Student Report French Translation
Showing 5 of 9 shared publications
- Abstract 2666: Preclinical investigations of concomitant tumor treating fields (TTFields) with cisplatin or paclitaxel for treatment of cervical cancer
- Abstract B028: Preclinical effects of Tumor Treating Fields (TTFields) applied with cisplatin for treatment of cervical cancer
- Abstract 7219: Preclinical investigations of concomitant tumor treating fields (TTFields) with cisplatin for treatment of cervical cancer
- Abstract 7134: Treatment of pancreatic cancer cells with tumor treating fields (TTFields) and PARP inhibitors
- EP.03F.04 Treatment of Non-Small Cell Lung Carcinoma (NSCLC) Cells with Tumor Treating Fields (TTFields) And DNA-Dependent Protein Kinase (PK) Inhibitors
Showing 5 of 9 shared publications
- Abstract 2666: Preclinical investigations of concomitant tumor treating fields (TTFields) with cisplatin or paclitaxel for treatment of cervical cancer
- Abstract B028: Preclinical effects of Tumor Treating Fields (TTFields) applied with cisplatin for treatment of cervical cancer
- Abstract 7219: Preclinical investigations of concomitant tumor treating fields (TTFields) with cisplatin for treatment of cervical cancer
- Abstract 7134: Treatment of pancreatic cancer cells with tumor treating fields (TTFields) and PARP inhibitors
- EP.03F.04 Treatment of Non-Small Cell Lung Carcinoma (NSCLC) Cells with Tumor Treating Fields (TTFields) And DNA-Dependent Protein Kinase (PK) Inhibitors
Showing 5 of 8 shared publications
- Abstract 2666: Preclinical investigations of concomitant tumor treating fields (TTFields) with cisplatin or paclitaxel for treatment of cervical cancer
- Abstract B028: Preclinical effects of Tumor Treating Fields (TTFields) applied with cisplatin for treatment of cervical cancer
- Abstract 7219: Preclinical investigations of concomitant tumor treating fields (TTFields) with cisplatin for treatment of cervical cancer
- Abstract 7134: Treatment of pancreatic cancer cells with tumor treating fields (TTFields) and PARP inhibitors
- EP.03F.04 Treatment of Non-Small Cell Lung Carcinoma (NSCLC) Cells with Tumor Treating Fields (TTFields) And DNA-Dependent Protein Kinase (PK) Inhibitors
Showing 5 of 8 shared publications
- Abstract 2666: Preclinical investigations of concomitant tumor treating fields (TTFields) with cisplatin or paclitaxel for treatment of cervical cancer
- Abstract B028: Preclinical effects of Tumor Treating Fields (TTFields) applied with cisplatin for treatment of cervical cancer
- Abstract 7219: Preclinical investigations of concomitant tumor treating fields (TTFields) with cisplatin for treatment of cervical cancer
- Abstract 7134: Treatment of pancreatic cancer cells with tumor treating fields (TTFields) and PARP inhibitors
- EP.03F.04 Treatment of Non-Small Cell Lung Carcinoma (NSCLC) Cells with Tumor Treating Fields (TTFields) And DNA-Dependent Protein Kinase (PK) Inhibitors
Showing 5 of 8 shared publications
- Exploring Self-Determination Outcomes of Racially and Ethnically Marginalized Students With Disabilities in Inclusive, General Education Classrooms
- Ecobehavioral Analysis of the Experiences of Students With Complex Support Needs in Different Classroom Types
- The Goal Setting Challenge App: Impact on Transition Goal Attainment Outcomes of Students With Disabilities
- Preliminary Reliability and Validity of the Self-Determination Inventory: Student Report French Translation
- The Self-Determination Inventory: Student Report American Sign Language Translation
Showing 5 of 7 shared publications
- Tumor Treating Fields (TTFields) Augment the Efficacy of Cisplatin for Treatment of Cervical Cancer, In Vitro and In Vivo
- Abstract 2666: Preclinical investigations of concomitant tumor treating fields (TTFields) with cisplatin or paclitaxel for treatment of cervical cancer
- Abstract B028: Preclinical effects of Tumor Treating Fields (TTFields) applied with cisplatin for treatment of cervical cancer
- Abstract 7219: Preclinical investigations of concomitant tumor treating fields (TTFields) with cisplatin for treatment of cervical cancer
- 341P: Efficacy of tumor treating fields (TTFields) in preclinical models of small cell lung carcinoma (SCLC)
Showing 5 of 7 shared publications
- Exploring Self-Determination Outcomes of Racially and Ethnically Marginalized Students With Disabilities in Inclusive, General Education Classrooms
- Ecobehavioral Analysis of the Experiences of Students With Complex Support Needs in Different Classroom Types
- An Investigation of IEP Quality Associated With Special Education Placement for Students With Complex Support Needs
- The Goal Setting Challenge App: Impact on Transition Goal Attainment Outcomes of Students With Disabilities
- The Self-Determination Inventory: Student Report American Sign Language Translation
Showing 5 of 6 shared publications
- Best practices for addressing missing data through multiple imputation
- Missing Data and Multiple Imputation Decision Tree
- Best Practices for Addressing Missing Data through Multiple Imputation
- Practicing theory building in a many modelers hackathon: A proof of concept
- Practicing Theory Building in a Many Modelers Hackathon
- Abstract 2666: Preclinical investigations of concomitant tumor treating fields (TTFields) with cisplatin or paclitaxel for treatment of cervical cancer
- Abstract B028: Preclinical effects of Tumor Treating Fields (TTFields) applied with cisplatin for treatment of cervical cancer
- Abstract 7219: Preclinical investigations of concomitant tumor treating fields (TTFields) with cisplatin for treatment of cervical cancer
- Abstract 7134: Treatment of pancreatic cancer cells with tumor treating fields (TTFields) and PARP inhibitors
- Abstract 4195: Efficacy of tumor treating fields (TTFields) applied with cisplatin and paclitaxel in cervical cancer cells
- Tumor Treating Fields (TTFields) Augment the Efficacy of Cisplatin for Treatment of Cervical Cancer, In Vitro and In Vivo
- Abstract 2666: Preclinical investigations of concomitant tumor treating fields (TTFields) with cisplatin or paclitaxel for treatment of cervical cancer
- Abstract B028: Preclinical effects of Tumor Treating Fields (TTFields) applied with cisplatin for treatment of cervical cancer
- Abstract 7219: Preclinical investigations of concomitant tumor treating fields (TTFields) with cisplatin for treatment of cervical cancer
- Abstract 4195: Efficacy of tumor treating fields (TTFields) applied with cisplatin and paclitaxel in cervical cancer cells
- Tumor Treating Fields (TTFields) Augment the Efficacy of Cisplatin for Treatment of Cervical Cancer, In Vitro and In Vivo
- Abstract 2666: Preclinical investigations of concomitant tumor treating fields (TTFields) with cisplatin or paclitaxel for treatment of cervical cancer
- Abstract B028: Preclinical effects of Tumor Treating Fields (TTFields) applied with cisplatin for treatment of cervical cancer
- Abstract 7219: Preclinical investigations of concomitant tumor treating fields (TTFields) with cisplatin for treatment of cervical cancer
- Abstract 4195: Efficacy of tumor treating fields (TTFields) applied with cisplatin and paclitaxel in cervical cancer cells
- Abstract 2666: Preclinical investigations of concomitant tumor treating fields (TTFields) with cisplatin or paclitaxel for treatment of cervical cancer
- Abstract B028: Preclinical effects of Tumor Treating Fields (TTFields) applied with cisplatin for treatment of cervical cancer
- Abstract 7219: Preclinical investigations of concomitant tumor treating fields (TTFields) with cisplatin for treatment of cervical cancer
- 341P: Efficacy of tumor treating fields (TTFields) in preclinical models of small cell lung carcinoma (SCLC)
- Abstract 4195: Efficacy of tumor treating fields (TTFields) applied with cisplatin and paclitaxel in cervical cancer cells
- Tumor Treating Fields (TTFields) Augment the Efficacy of Cisplatin for Treatment of Cervical Cancer, In Vitro and In Vivo
- Abstract 2666: Preclinical investigations of concomitant tumor treating fields (TTFields) with cisplatin or paclitaxel for treatment of cervical cancer
- Abstract B028: Preclinical effects of Tumor Treating Fields (TTFields) applied with cisplatin for treatment of cervical cancer
- Abstract 7219: Preclinical investigations of concomitant tumor treating fields (TTFields) with cisplatin for treatment of cervical cancer
- Abstract 4195: Efficacy of tumor treating fields (TTFields) applied with cisplatin and paclitaxel in cervical cancer cells
- Tumor Treating Fields (TTFields) Augment the Efficacy of Cisplatin for Treatment of Cervical Cancer, In Vitro and In Vivo
- Abstract 2666: Preclinical investigations of concomitant tumor treating fields (TTFields) with cisplatin or paclitaxel for treatment of cervical cancer
- Abstract B028: Preclinical effects of Tumor Treating Fields (TTFields) applied with cisplatin for treatment of cervical cancer
- Abstract 7219: Preclinical investigations of concomitant tumor treating fields (TTFields) with cisplatin for treatment of cervical cancer
- Abstract 4195: Efficacy of tumor treating fields (TTFields) applied with cisplatin and paclitaxel in cervical cancer cells
Similar Researchers
Based on overlapping research topics